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INTRODUCTION
Temporomandibular disorder (TMDs) present 
signs and symptoms that affect the masticatory muscles, 
temporomandibular joint (TMJ) or both (1). The patient 
may report signs and symptoms such as muscle and TMJ 
pain (2), tenderness to palpation on the TMJ and face, 
restriction of mandibular movement and joint sounds (3). 
The majority of patients suffering from TMD 
obtain relief of symptoms with different treatments 
(4). The use of low-level laser therapy (LLLT) for 
the treatment of musculoskeletal pain syndromes 
has become common (5-9) and the affected region is 
usually irradiated to cause attenuation of symptoms 
(10-12). LLLT presents biologic effects as increased 
pain tolerance due to changes in cellular membrane 
potency, vasodilatation, reduction of edema, increase 
in intracellular metabolism and acceleration of wound 
healing (13). The antiinflammatory (14), analgesic, and 
biomodulatory effects of lasers are recognized. 
The gallium-aluminum-arsenide laser (GaAlAs) 
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is an infrared ray with wavelength of 830 nm (15) that 
is used for treating a wide array of conditions (16) 
and its effect depends on dose application (17), target 
tissue, and immunological system conditions (18). This 
study evaluated the influence of GaAlAs (λ 830 nm) 
application in subjects with TMJ pain by palpation of 
the lateral pole of the condyle, use of the visual analogue 
scale (VAS) and assessment of the range of mandibular 
movements.
MATERIAL AND METHODS
Forty patients with articular symptoms were 
selected from the TMJ Disorders Service at Ribeirão 
Preto Dental School, University of São Paulo based on 
a standardized and comprehensive clinical examination 
(12). The exclusion criteria were: use of medications 
for pain control, use of occlusal splint, and clinical 
conditions in which LLLT could be contra-indicated 
such as aggressive tumor and infections. The subjects 
were informed about the research purposes and signed 
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an informed consent form approved by the Research 
Ethics Committee (Process #2002.1.689.58.4). They 
were randomly divided into an treatment and a placebo 
group with 20 subjects each. 
TMJ pain was quantified by the VAS, where 0 
indicated “no pain” and 10 indicated “the worst possible 
pain”, during palpation of the lateral pole of the condyle, 
and measurements of mouth opening, right and left 
lateral excursions were obtained in all evaluations by 
only one operator who was previously calibrated to do 
these procedures of same manner. The measurement 
of the mouth opening was made by use of a millimeter 
ruler that was placed at the incisal edge of the maxillary 
central incisor that is the most vertically oriented and 
measured vertically to the labioincisal edge of the 
opposing mandibular incisor. For measurement of the 
right and left lateral excursions, the patient was asked 
to bite, and a line corresponding to the midline between 
the upper incisors was drawn on the labial surface of 
the opposite lower incisor. Then, the patient was asked 
to move his/her mandible towards the right or left 
shoulder as far as possible. The examiner measured the 
point corresponding to the maximum lateral excursion 
of the lower midline (19). These evaluations were 
performed at the following time points: E1, before laser 
application; E2, immediately after each of 8 applications; 
the laser was applied twice a week during 4 weeks, 
as recommended by the World Association of Laser 
Therapy; E3, 7 days after the last application; and E4, 
30 days after the last application.
The LLL used in the study was a GaAlAs laser 
source (Physiolux Dual P.5040; Bioset Industry of 
Electronic Technology Ltda., São Carlos, SP, Brazil) 
emitting a continuous laser beam (830 nm wavelength; 
40 mW power output). The treated group received the 
effective dose (5 J/cm² per point, 10 s) and the other 
group received a placebo application (0 J/cm² per point, 
15 s) on the affected points - superior, anterior, posterior, 
and posterior-inferior of the lateral pole of the condyle 
- which were demarcated bilaterally with a pencil, with 
the aid of a guide with standardized circular perforations 
(12) (Fig. 1). 
After completion of the study, the patients of the 
placebo group were treated according  to their individual 
needs and disorders, so that these subjects would not 
leave without treatment.
The mouth opening was registered before (E1), 
immediately after laser applications (E2), after 7 days 
(E3) and 30 days (E4). 
Data obtained were subjected to parametric 
(ANOVA) and non-parametric (Kruskal-Wallis) 
statistical analysis. A significance level of 1% was set 
for all analyses.
RESULTS 
Table 1 presents the mean values from VAS 
for pain symptoms of the pressured regions in the 
evaluations for the groups that received active and 
placebo doses, corresponding to right and left sides. This 
experimental design was submitted to statistical analysis 
by the Kruskal-Wallis test, which indicated significant 
difference (p<0.01) between the groups and among the 
evaluations on both the right and left condyles.
Table 2 presents the mean values from the  mouth 
opening measurements. This experimental design was 
submitted to statistical analysis by ANOVA and Tukey’s 
Figure 1. Illustration of the guide with standardized circular 
perforations used to demarcate the points for LLLT.
Table 1. Mean VAS values for pain symptoms of the pressured 
regions in the evaluations for the groups that received either an 
active laser dose or a placebo dose.
Evaluations
Right lateral pole 
condyle
Left lateral pole 
condyle
Active Placebo Active Placebo
E1 5.40 5.80 6.45 6.25
E2 2.10 4.45 3.05 5.60
E3 2.50 5.15 2.50 5.60
E4 2.95 5.60 2.95 6.30
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test, which indicated no significant difference among the 
evaluations (p>0.01), but showed significant difference 
(p<0.01) between the groups at the E4. 
Table 3 shows the mean values of measurements 
of right and left lateral mandibular excursions. This 
experimental design were submitted to statistical analysis 
by Kruskal-Wallis test, which indicated statistically 
significant difference (p<0.01) between the groups.
DISCUSSION
The initial treatment of TMD frequently focuses 
on the use of noninvasive pain control methods (20). 
LLLT was applied in this study as a noninvasive auxiliary 
therapy for pain control in patients with TMD. It has 
been employed as an agent that have biomodulatory, 
antiinflammatory and analgesic effects on physiological, 
cellular and systemic responses (12). LLLT has been 
considered effective in reducing pain and muscular 
tension, thus, improving the life quality of patients (12).
Analyzing the painful symptoms evaluations at 
the right and the left sides in the treated group, there 
was a significant difference from E1 to E2, suggesting 
the immediate effect of laser applications. However, 
no significant differences were observed between 
the following evaluations, confirming that LLLT was 
effective in attenuating the painful symptoms only 
during the 4-week application period. In the same way 
as observed in previous studies (9,11), this positive result 
reinforces the biologic effects of laser therapy, such 
as increased pain tolerance due to changes in cellular 
membrane potency, vasodilatation, reduction of edema, 
increase in intracellular metabolism and acceleration of 
wound healing (12). However, in spite of being used for 
treating several conditions (15), LLLT effects depend 
on dosimetry and systemic corporal conditions (17).
In the group of patients that received the placebo 
dose, there was no significant reduction of painful 
symptoms from E1 to E2, and neither among E2, E3 
and and E4. Therefore, the power of the placebo effect 
has not been demonstrated in the present study. The 
maintenance of pain at the later evaluations (E3 and 
E4) indicates that no placebo effect occurred in this 
research. These results differ from those of a previous 
investigation (10), which demonstrated  significant pain 
reduction in both treatment and placebo groups, though 
with increased mandibular movement in the treated 
group only. In our study, the significant difference 
between the groups indicates that the active laser therapy 
promoted suitable effects. 
Before the start of the applications, both groups 
received explanations about the study, as specified in the 
informed consent form. Thus, the placebo effect, widely 
discussed in another study (11) may have occurred even 
during the application period in the treated group. The 
same should be considered with respect to the effect of 
the examiner/patient relationship and the psychological 
effect of LLLT.
In this research, a significant improvement in 
the range of right and left mandibular movements was 
observed in the treated group when the results were 
compared between the groups at the final evaluation 
(E4). This suggests that the laser therapy was efficient in 
promoting an increase of mandibular movements in the 
patients that received the active laser dose following the 
proposed protocol. Similar results were found by others 
authors (4,10). This is probably due to the analgesic effect 
of low-intensity lasers (3), which was demonstrated 
in this study by the decrease in the VAS scores (11). 
On the other hand, the placebo group did not show 
significant differences among the four evaluation time 
points, indicating the inefficacy of placebo applications 
for decrease of pain and improvement in the range of 
Table 2. The mean values from the measurements of mouth 
opening (mm) in the evaluations for the groups that received 
either an active laser dose or a placebo dose.
Evaluations Active laser dose Placebo dose 
E1 48.25 47.90
E2 50.60 47.30
E3 50.25 47.05
E4 50.55 46.35
Table 3. Mean values of measurements of right and left lateral 
excursion mandibular movements (mm) in the evaluations for the 
groups that received either an active laser dose or a placebo dose.
Evaluations
Active laser dose Placebo dose
Right Left Right Left
E1 7.20 6.85 6.85 6.15
E2 8.95 9.05 7.15 6.80
E3 8.65 9.45 6.85 6.90
E4 9.25 9.70 6.75 6.70
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mandibular movements. 
The LLLT was applied on the selected points 
considering the presence of nociceptors in the 
periarticular tissues (discal ligaments, capsular ligaments 
and retrodiscal tissues), because these structures 
are involved in the TMJ pain. Similar points were 
evaluated in other studies by some authors (5,7,8). 
Internal derangement of TMJ is frequently associated 
with pain due the inflammatory disorders that occur 
when the collateral ligaments are extended or ruptured. 
Consequently, any mandibular movement that extends 
or compresses these tissues will induce an increase of 
pain, especially during muscular and articular palpations 
(3). The typical clinical finding in patients with TMJ 
dysfunction is the tenderness of the TMJ during palpation 
and mandibular lateral excursion (4). A considerable 
part of population groups studied present at least one 
sign or symptom of TMD (3), and the main complaint 
of patients with this dysfunction or the reason why they 
seek treatment is some type of joint or muscular pain (2).
Regarding the evaluation of TMD pain, much 
attention has been given to measuring the intensity of 
pain upon palpation of the masticatory muscles and 
TMJ. The VAS is also commonly used to measure pain 
in subjects with TMD (4,5,8,14), and it was employed 
in this study to quantify the pain in the lateral pole of the 
condyle. The measurements of mandibular movements 
were applied as a functional tool to observe the outcomes 
on articular pain after effective and placebo laser 
applications.
The importance of investigating the actual 
analgesic efficacy of LLLT lies on the fact that TMD 
symptoms have been treated by a wide array of  methods 
separately, such as interocclusal splint, medication, 
physical therapy and transcutaneous electric nerve 
stimulation (TENS); in most cases, however, better 
outcome is achieved when therapies are associated (3), 
and lasers can be of great value. 
The successful treatment of pathologies in the 
maxillofacial region using LLLT has been demonstrated 
(6). Its use in the treatment of muscular and joint 
dysfunctions is due to its recognized analgesic effect, 
explained by the increase of beta endorphin level, 
increase of pain discharge threshold, decrease of 
bradykinin and histamine release, increase of lymphatic 
flow, decrease of edema and algesic substances, increase 
of blood supply, time reduction of inflammation, and 
promotion of muscle relaxation (4). 
Like in any therapy, patients respond similarly to 
LLLT. Patient response depend not only on the type of 
laser, but also on the target tissue and immunological 
system conditions. An unsatisfactory outcome can be due 
to very low doses, very high doses, incorrect diagnosis, 
small number of sessions, inadequate energy density, 
among others (17).
In this study, the range of mandibular lateral 
movements and the painful symptoms on the lateral 
pole of the condyle were evaluated in patients with 
TMD after LLLT to verify the efficacy of this therapy. 
The results showed that the laser therapy was effective 
in the improvement of the range of mandibular lateral 
movements and promoted a significant reduction of 
pain symptoms. 
RESUMO
O objetivo deste estudo foi avaliar a eficácia da terapia 
com laser de baixa intensidade na melhora dos movimentos 
mandibulares e dos sintomas dolorosos em pacientes com 
disfunção temporomandibular (DTM). Quarenta pacientes foram 
aleatoriamente divididos em dois grupos (n=20): Grupo 1 recebeu 
a dose efetiva (laser de AsGaAl 830 nm, 40 mW, 5 J/cm2) e Grupo 
2 recebeu a aplicação placebo (0 J/cm2), no modo contínuo no pólo 
lateral do côndilo afetado: superior, anterior,  e posterior-posterior 
e inferior, 2 vezes por semana, por 2 meses. Quatro avaliações 
foram feitas: A1 (antes da aplicação), A2 (imediatamente após 
a última aplicação), A3 (uma semana após a última aplicação) 
e A4 (um mes após a última aplicação). O teste estatístico de 
Kruskal-Wallis mostrou melhoras significativas (p<0,01) nos 
sintomas dolorosos no grupo 1, diferentemente do grupo 2. Uma 
melhora significativa na extensão dos movimentos mandibulares 
foi observada quando os resultados foram comparados entre os 
dois grupos na A4. A aplicação do laser é uma terapia de suporte 
no tratamento da DTM, uma vez que resultou em imediata redução 
dos sintomas dolorosos e aumento na extensão dos movimentos 
mandibulares no grupo experimental. Os mesmos resultados não 
foram observados no grupo placebo.
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